Drug: Bevacizumab Injury: Hypertension Quarter: 2016Q3
Total Records: 97 Number of Pages: 5
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 125281901 | BEVACIZUMAB | Hypertension | JANSSEN | 0.00 | 0 | 20160705 | US | |
| 125386481 | Bevacizumab | Hypertension | CIPLA | 0.00 | 0 | 20160708 | BE | |
| 125393341 | Bevacizumab | Hypertension | CIPLA | 0.00 | 0 | 20160708 | BE | |
| 125404372 | Bevacizumab | Hypertension | ROCHE | 66.00 YR | M | 55 KG | 20160808 | US |
| 125477611 | Bevacizumab | Hypertension | ROCHE | 58.00 YR | F | 49 KG | 20160712 | US |
| 125483631 | BEVACIZUMAB | Hypertension | MERCK | 0.00 | 0 | 20160712 | US | |
| 125484302 | Bevacizumab | Hypertension | ROCHE | 83.00 YR | F | 70 KG | 20160916 | US |
| 125509871 | Bevacizumab | Hypertension | ROCHE | 0.00 | 0 | 20160713 | GR | |
| 125516301 | Bevacizumab | Hypertension | CIPLA | 0.00 | 0 | 20160713 | US | |
| 125516341 | Bevacizumab | Hypertension | CIPLA | 0.00 | 0 | 20160713 | US | |
| 125620512 | BEVACIZUMAB | Hypertension | MERCK | 0.00 | 0 | 20160725 | US | |
| 125653661 | Bevacizumab | Hypertension | CELGENE | 0.00 | 0 | 20160718 | US | |
| 125688741 | Bevacizumab | Hypertension | ROCHE | 44.00 YR | F | 0 | 20160719 | JP |
| 125789224 | BEVACIZUMAB | Hypertension | ACTAVIS | 0.00 | M | 0 | 20160810 | GB |
| 125799942 | BEVACIZUMAB | Hypertension | MERCK | 58.00 YR | F | 0 | 20160801 | GB |
| 125820362 | BEVACIZUMAB | Hypertension | MERCK | 0.00 | M | 0 | 20160805 | GB |
| 125839081 | BEVACIZUMAB | Hypertension | FRESENIUS KABI | 57.00 YR | M | 0 | 20160722 | GB |
| 125900471 | BEVACIZUMAB | Hypertension | MYLAN | 0.00 | 0 | 20160725 | GB | |
| 125965191 | BEVACIZUMAB | Hypertension | TEVA | 0.00 | M | 0 | 20160727 | GB |
| 126009073 | Bevacizumab | Hypertension | ROCHE | 0.00 | 0 | 20160901 | US |
Total Records: 97 Number of Pages: 5